← Back to the biomarker database

GABA, glutamate and glutamine: the pathway in the body · Biomarker & Laboratory Analysis

This page shows the biochemical pathway behind the laboratory value GABA, glutamate, glutamine: which stations follow one another, which enzymes carry out each step and which cofactors they use. Every statement has a source. The page describes general textbook knowledge and says nothing about any individual person.

In brief

Glutamate and GABA are messengers of the nervous system: glutamate excites, GABA inhibits. Nerve cells make GABA from glutamate, and astrocytes resupply both via glutamine. If one side predominates, the balance of excitation and inhibition shifts.

8 stations · 7 sources
ORYIn the nerve cellIn the astrocyteGlutaminaseGAD65, GAD67Vitamin B6 (PLP)VGAT, VGLUT (vesicle)Glutamine synthetaseATPAmmoniaGABA transaminaseVitamin B6 (PLP)α-KetoglutarateSSADHNAD⁺uptake from the cleftVigabatrinGlutamineamino acid from astrocytesGlutamateexcitatory messengerGABAinhibitory messengerSynaptic cleftrelease from vesiclesIn the astrocyteuptake via transportersGlutamine (astrocyte)returns to the nerve cellSuccinic semialdehydeintermediate of GABA breakdownSuccinatelink to the citric acid cycle

Swipe the graphic sideways

The pathway step by step

Each station states what the compound does there. Three signs: ↑ supplies — builds up or makes available · ↓ depletes — inhibits, consumes or withholds · ↕ both, depending on amount. Behind it stands what the statement rests on: established physiology, observed in studies, or contested. The signs do not grade; they name the direction.

  1. Glutamine → Glutamate Glutaminase The enzyme glutaminase removes an amino group from glutamine, forming glutamate, the brain's main excitatory messenger. It excites the receiving cell via NMDA and AMPA receptors. Source 1, 4↕ both, depending on amount Glutamate excites the receiving cell via receptors such as NMDA and AMPA receptors, which let sodium and calcium flow in. At the same time it is the starting material for GABA and part of energy metabolism. established physiology Source 5, 2
    ⚖ When the balance tips

    too much — If glutamate stays in the cleft for a long time, the receptors stay open; in cell culture and animal models more calcium then flows into the nerve cell than it can buffer.

    too little — If little glutamate is available, excitatory transmission is weaker, and less starting material is available for making GABA.

    observed in studies · Source 5

  2. Glutamate → GABA GAD65, GAD67 · Vitamin B6 (PLP) In certain nerve cells, glutamate decarboxylase (GAD65, GAD67) removes a carboxyl group from glutamate, forming GABA, the main inhibitory messenger. The enzyme needs pyridoxal phosphate, the active form of vitamin B6. GABA dampens excitation. Source 3, 2↓ depletes GABA inhibits the receiving cell: at the GABA-A receptor it opens a chloride channel, at the GABA-B receptor it acts via G proteins; the cell becomes harder to excite. In this way GABA balances glutamate. established physiology Source 2
    ⚖ When the balance tips

    too much — If a lot of GABA is present, inhibition predominates and nerve cells become harder to excite; GABA transaminase breaks down the excess in astrocytes and nerve cells.

    too little — If little PLP is available, more GAD is present as the inactive form without cofactor, and less GABA forms; inhibition is then weaker than excitation.

    observed in studies · Source 3, 2

  3. GABA → Synaptic cleft · VGAT, VGLUT (vesicle) Vesicular transporters load GABA and glutamate into storage vesicles. On a signal, the cells release the contents into the gap between two nerve cells, where they bind to receptors. How long they stay there sets the signal strength. Source 1, 2↕ both, depending on amount In the cleft, excitation and inhibition meet: how long glutamate and GABA stay there determines the strength of the signal. Rapid uptake into astrocytes and nerve cells ends it. established physiology Source 1, 5
    ⚖ When the balance tips

    too much — If the messengers are cleared from the cleft more slowly, they act longer and also at neighbouring synapses; with glutamate, more calcium then flows into the cells.

    too little — If little is released, for example because the store in the vesicles is small, the signal at the receiving cell is weaker.

    observed in studies · Source 5, 1

  4. In the astrocyte → Glutamine (astrocyte) Glutamine synthetase · ATP, Ammonia Glutamine synthetase adds an amino group from ammonia to glutamate, using up ATP. The astrocyte passes the glutamine back to the nerve cell, closing the cycle. At the same time ammonia is bound. Source 1, 4↑ supplies Glutamine synthetase binds ammonia that would otherwise remain free in the brain, and makes glutamate transportable without excitatory action. In the brain the enzyme is found mainly in astrocytes. established physiology Source 1, 4
    ⚖ When the balance tips

    too much — If a lot of ammonia arises, glutamine synthetase binds more of it and uses more ATP to do so; the astrocyte releases the additional glutamine.

    too little — If glutamine synthetase works more slowly, for example when little Mg-ATP is available, more glutamate and ammonia remain in the astrocyte, and the nerve cell receives less glutamine.

    observed in studies · Source 1, 7

  5. In the astrocyte → Succinic semialdehyde GABA transaminase · Vitamin B6 (PLP), α-Ketoglutarate GABA transaminase transfers the amino group of GABA to α-ketoglutarate. This yields succinic semialdehyde and glutamate. This enzyme also works with pyridoxal phosphate. This ends the action of GABA. Source 4, 1↓ depletes GABA transaminase ends the action of GABA for good and recovers glutamate in the process, so the amino group is not lost. If the enzyme is inhibited, GABA rises, as the prescribing information for vigabatrin describes. established physiology Source 4, 6
    ⚖ When the balance tips

    too much — If GABA transaminase runs fast, GABA is broken down quickly, and less of it remains for inhibition.

    too little — If GABA transaminase is slowed, as described for vigabatrin, GABA is broken down more slowly and is present in the nervous system in higher amounts.

    established physiology · Source 4, 6

  6. Succinic semialdehyde → Succinate SSADH · NAD⁺ Succinic semialdehyde dehydrogenase turns it into succinate, an intermediate of the citric acid cycle. Via this shunt, GABA flows back into energy metabolism. With little NAD⁺, this step runs more slowly. Source 4, 2↑ supplies Via succinate, the carbon skeleton of GABA enters the citric acid cycle and provides energy there; this loop is called the GABA shunt. NAD⁺ accepts hydrogen in the process. established physiology Source 4, 2
    ⚖ When the balance tips

    too much — If a lot of GABA drains away via the shunt, more carbon enters the citric acid cycle, and less GABA remains for signalling.

    too little — If little NAD⁺ is available, the dehydrogenase works more slowly, and succinic semialdehyde is converted to succinate more sluggishly.

    established physiology · Source 4, 2

Further stations

Cofactors in this pathway

What acts on this pathway

Sources

  1. Bak LK, Schousboe A, Waagepetersen HS. The glutamate/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer. J Neurochem 2006 · PubMed 16787421
  2. Andersen JV, Schousboe A et al. Milestone Review: Metabolic dynamics of glutamate and GABA mediated neurotransmission - The essential roles of astrocytes. J Neurochem 2023 · PubMed 36919769
  3. Martin DL, Rimvall K. Regulation of gamma-aminobutyric acid synthesis in the brain. J Neurochem 1993 · PubMed 8419527
  4. Waagepetersen HS, Sonnewald U, Schousboe A. Compartmentation of glutamine, glutamate, and GABA metabolism in neurons and astrocytes: functional implications. Neuroscientist 2003 · PubMed 14580123
  5. Danbolt NC. Glutamate uptake. Prog Neurobiol 2001 · PubMed 11369436
  6. US prescribing information Vigabatrin (DailyMed), section 12.1 Mechanism of Action · Prescribing information
  7. Eisenberg D, Gill HS, Pfluegl GM et al. Structure-function relationships of glutamine synthetases. Biochim Biophys Acta 2000 · PubMed 10708854

Related pathways

As of 2026-09-16. Draft written by Claude to schema v2; sources checked in PubMed; expert review pending
Legal notice Privacy policy All biomarkers